Recherche avancée

Le Dr Colin S. Goldschmidt, MD, est directeur général de Douglass Hanly Moir Pathology Pty Ltd. et directeur général, MD et directeur exécutif de Sonic Healthcare Ltd. Il siège au conseil d'administration de Sonic Healthcare Holding Co, Sonic Healthcare Ltd, Health Services Laboratories LLP, Sonic Healthcare USA, Inc, TDL Genetics Ltd et The Doctors Laboratory Ltd. Le Dr Goldschmidt était auparavant employé comme directeur non exécutif par Independent Practitioner Network Pty Ltd. et comme directeur non exécutif indépendant par Silex Systems Ltd.

Actuellement, Peter Goldschmidt occupe le poste de président du conseil d'administration de STADA Arzneimittel AG, de directeur général de Fougera Pharmaceuticals, Inc. et de président de Sandoz, Inc. Il est également membre du conseil d'administration de l'Association for Accessible Medicines. Auparavant, il a occupé les postes de chef du marketing chez Novartis Pharma (Suède), de président national chez Novartis Healthcare Philippines, Inc. et de chef de l'Europe centrale et orientale chez Sandoz International GmbH, ainsi que de chef des ventes et du marketing chez Novartis Pharmaceuticals. Peter Goldschmidt a obtenu un diplôme d'études supérieures et un diplôme de premier cycle à l'université de Mnster.

M. Colin Bell est Group Chief Compliance Officer chez HSBC Holdings Plc. Il est membre du conseil d'administration de Quantexa Ltd. et de HSBC Bank Plc. M. Bell a été précédemment employé comme Head-Compliance & Operational Risk Control par UBS Ltd. et comme Global Head-Operational Risk Control par UBS Reorganisation 2005-04 Ltd.

Colin Browne est membre du conseil d'administration de Footwear Distributors & Retailers of America, président de l'American Apparel & Footwear Association et directeur de l'exploitation d'Under Armour, Inc. Dans le passé, M. Browne a occupé le poste de vice-président et directeur général chez VF Corp, de directeur général pour l'Asie chez Pentland Brands Plc et de vice-président exécutif pour les chaussures et les accessoires chez Fung Group.

Colin Grahame Storrie est membre de l'Australian Institute of Co. Directors et siège au conseil d'administration de 7 autres sociétés. Dans le passé, il a été directeur financier d'AMP Ltd. directeur exécutif d'AMP Group Finance Services Ltd. et directeur financier d'AMP Ltd. (Investment Portfolio) (toutes deux filiales d'AMP Ltd.) et directeur financier de Qantas Airways Ltd. M. Storrie a obtenu un diplôme de premier cycle à l'université de Wollongong.

Actuellement, Colin V. Reed est président et directeur général de Ryman Hospitality Properties, Inc. Il est également membre du conseil d'administration de First Horizon Corp. (Tennessee). Dans sa carrière antérieure, il a occupé les postes de président et de directeur général de Gaylord Entertainment Co. et de président de JCC Holding Co., de directeur financier et de vice-président exécutif de Caesars License Co. LLC et assistant exécutif chez Holiday Corp.

Colin Naughton is currently the President-Asia Region at Autoliv, Inc. He previously served as the President at Autoliv Japan Ltd.
and Autoliv Thailand Ltd.
Mr. Naughton completed his undergraduate degree at the National University of Ireland Galway.

Colin Michael Penny is currently the Chief Information Officer & Senior VP-Technology at Hydro One Networks, Inc. He is also currently the Chief Information Officer at Algonquin Power & Utilities Corp.
Previously, he worked as the Director at Canadian Cyber Threat Exchange Cctx from 2016 to 2018.
He also held the position of Chief Information Officer & Senior VP-Technology at Hydro One, Inc. and Hydro One Ltd.
from 2009 to 2018.
Mr. Penny completed his undergraduate degree at Queen's University.

Colin Black occupe le poste de directeur de l'exploitation de CrowdStrike Holdings, Inc. et de directeur de l'exploitation de CrowdStrike, Inc. (une filiale de CrowdStrike Holdings, Inc.). M. Black est également secrétaire et directeur de la Fondation Crowdstrike. Dans sa carrière antérieure, il a occupé le poste de directeur des systèmes d'information chez Kratos Defense & Security Solutions, Inc. et de directeur des systèmes d'information chez Cymer, Inc.

Colin Dyer est un homme d'affaires qui a fondé WorldWide Retail Exchange LLC et qui a été à la tête de 6 entreprises différentes. M. Dyer est membre du conseil d'administration d'Altus Group Ltd, The Executives Club of Chicago, Paramount Group, Inc. et Unibail-Rodamco-Westfield SE (ancien président du conseil de surveillance) et membre du Chicago Club et de la Royal Institution of Chartered Surveyors. Par le passé, Colin Dyer a occupé le poste de directeur non exécutif chez Jones Lang LaSalle, Inc. et de directeur général de Jones Lang LaSalle Americas, Inc. (une filiale de Jones Lang LaSalle, Inc.), directeur de clientèle chez McKinsey & Co, Inc. et président du conseil de surveillance d'Unibail-Rodamco-Westfield NV, directeur général de Courtaulds Textiles Plc et directeur général de WorldWide Retail Exchange LLC. M. Dyer a obtenu un diplôme de premier cycle à l'Imperial College de Londres et un MBA à l'INSEAD.

Colin Hunt currently works at Allied Irish Banks Plc, as Chief Executive Officer & Executive Director from 2019, AIB Group plc, as Chief Executive Officer & Executive Director from 2019, and Allied Irish Banks Plc (Private Banking), as Chief Executive Officer & Executive Director from 2019.
Dr. Hunt also formerly worked at Goodbody Stockbrokers UC, as Research Director, Aer Lingus Group DAC, as Non-Independent Non-Executive Director from 2011 to 2014, Macquarie Capital Ireland DAC, as Managing Director, and Bank of Ireland Group Treasury, as Head-Trading Research from 1996 to 1998.
Dr. Hunt received his undergraduate degree from Trinity College Dublin and doctorate degree from University College Cork.

Actuellement, Colin Shannon est président du conseil, président et chef de la direction de PRA Health Sciences, Inc. et président du conseil, président et chef de la direction de Pharmaceutical Research Associates, Inc. et président de PRA International Operations, Inc. et président de PRA Holdings, Inc. (qui sont toutes des filiales de PRA Health Sciences, Inc.). Il est également membre du conseil d'administration de Pharm Research Associates (UK) Ltd. et d'IMP Logistics UK Ltd. et membre de l'Association of Chartered Certified Accountants. Colin Shannon a précédemment occupé le poste de vice-président exécutif des opérations cliniques mondiales chez Pharmaceutical Product Development LLC et de vice-président exécutif des opérations cliniques mondiales chez PPD Development LP. Il a obtenu un diplôme d'études supérieures et un MBA de la City University de Londres.

Colin L.
Simpson is currently the Chief Financial Officer at Manulife Financial Corp.
He previously worked as the Director-Investor Relations at Aviva Plc from 2013 to 2015, a Research Analyst at Goldman Sachs International from 2008 to 2013, and as the Chief Financial Officer at Aviva Plc in 2022.
He also worked as a Research Analyst at Bear Stearns International Ltd.
and as the Chief Financial Officer at Aviva Canada, Inc. Mr. Simpson completed his undergraduate degree at the University of Cape Town.

Colin Peter Kilty siège au conseil d'administration de la Red Deer Regional Health Foundation et est vice-président principal de l'exploitation des carburants de détail et commerciaux chez Parkland Corp. Dans le passé, il a occupé les postes de président du conseil d'administration de Providence Healthcare, de président du conseil d'administration de la Canadian Independent Petroleum Marketers Association et de premier vice-président des opérations des détaillants de la Société Canadian Tire. Ltd. et président de La Société pétrolière Canadian Tire, Inc. (une filiale de la Société Canadian Tire Ltée). M. Kilty a obtenu un diplôme de premier cycle de l'Université de Western Ontario et un MBA de la Schulich School of Business.

Actuellement, Colin Bond est président non exécutif de European ScreeningPort GmbH et directeur financier de Vifor Pharma AG, directeur financier de Vifor Pharma Management AG (une filiale de Vifor Pharma AG). Il est également membre du conseil d'administration de Siegfried Holding AG, de Vifor Fresenius Medical Care Renal Pharma Ltd. et de BioPharma Credit PLC et membre de la Royal Pharmaceutical Society of Great Britain. Colin Bond a précédemment occupé le poste de directeur financier d'Evotec SE, de directeur financier de Great Lakes Chemical Corp, de directeur financier de Novelis AG, de directeur financier de Novelis Europe Holdings Ltd, de directeur financier de Jet Aviation Management AG, de directeur financier d'Ecolab (Schweiz) GmbH, d'auditeur de PricewaterhouseCoopers LLP, d'auditeur d'Arthur Andersen AG et d'auditeur de Procter & Gamble AG. Colin Bond a obtenu un MBA de la London Business School et un diplôme de premier cycle de l'université d'Aston.

M. Colin D. Meadows est Senior MD & Head-Private Markets chez Invesco Ltd. Il siège au conseil d'administration d'Invesco Mortgage Capital, Inc. et d'Atlantic Trust Co., NA (Géorgie). Il a obtenu son diplôme de premier cycle à l'université Andrews et un diplôme de deuxième cycle à la Harvard Law School.

Colin S. Mooney occupe le poste de Chief Digital Officer & Senior Vice President chez Robert Half International, Inc.

Colin Moore est Global Chief Investment Officer & Executive VP chez Ameriprise Financial, Inc. et Global Chief Investment Officer & Executive VP chez Columbia Cent Clo Advisers, LLC, Global Chief Investment Officer chez Columbia Wanger Asset Management LLC, Global Chief Investment Officer chez Columbia Management Investment Advisers LLC et Global Chief Investment Officer chez Columbia Threadneedle Investments (Missouri) (qui sont toutes des filiales d'Ameriprise Financial, Inc.). Colin Moore est également Senior Vice President de Tri-Continental Corp. et Senior Vice President de Columbia Seligman Premium Technology Growth Fund, Inc. Dans le passé, il a occupé les postes de Chief Investment Officer chez Columbia Management Advisors, Inc, de gestionnaire de portefeuille chez Putnam Investment Management LLC, de directeur de la recherche chez Rockefeller & Co, Inc et de responsable des investissements chez Banc of America Capital Management LLC.

Colin K.
Gruending is currently the Director at Gaz Métro LNG LP.
He is also the Executive VP & President-Liquid Pipeline at Enbridge, Inc. and a Member-Governing Board at Canada's Sports Hall of Fame.
Previously, he worked as a Director at Noverco, Inc. and as the Chief Financial Officer at Enbridge Income Fund Holdings, Inc. He also held the position of Chief Financial Officer at Enbridge Management Services, Inc. Mr. Gruending completed his undergraduate degree at the University of Saskatchewan.

Colin Richard Day currently works at Premier Foods Plc, as Non-Executive Chairman from 2019, Factory Mutual Insurance Co., as Director from 2021, Meggitt Ltd., as Non-Executive Director from 2015, and various other companies.
Mr. Day also formerly worked at WPP 2012 Ltd., as Independent Non-Executive Director from 2011 to 2013, ABB Ltd., as Finance Director, Imperial Brands Plc, as Non-Executive Director from 2005 to 2007, and various other companies.
Mr. Day received his Masters Business Admin degree from Cranfield School of Management.

Colin J. Meyer est directeur de la recherche et du développement, vice-président exécutif chez Reata Pharmaceuticals, Inc. Il a obtenu un diplôme de premier cycle à l'université de Virginie, un doctorat au centre médical Southwestern de l'université du Texas et un MBA à la SMU-Cox School of Business.

Colin Kincaid is currently the Chief Product Officer at Casa Systems, Inc. Prior to this, he worked as an Engineering Director at Cisco Systems, Inc. and Maker Communications, Inc. He also held Principal positions at Nexion, Inc., Xedia Corp., and ASCOM Corp.
Mr. Kincaid completed his undergraduate degree at Boston University.

Steven Goldschmidt currently works at Real Estate Board of New York, Inc., as Member-the Executive Cmte & NYRS Masters Program.

Amnon Goldschmidt is currently the Chairman of A.
Goldschmidt Investments Ltd., and a Director at Israel Mezzanine Fund LP, FIMI 2001 Ltd., and Harel Recanati Investment House Ltd.
He previously served as Chairman of Memador Ltd., and as a Director at First Israel Mezzanine Investors Ltd., Solbar Food Technologies Ltd., and FIMI Opportunity 2005 Ltd.
He was also an Independent Director at The First International Bank of Israel Ltd.
Dr. Goldschmidt holds a doctorate from Simon Fraser University, and undergraduate and MBA degrees from The Hebrew University of Jerusalem.

Collene Goldschmidt joined Sanlam Private Equity in 2005 and is financial manager responsible for the financial, administrative and operational activities of the business.
She began her professional career after completing her articles with Grant Thornton International.
In 2000, she joined Sanlam Employee Benefits and Multi Data as an Accountant.
As the Multi Data business grew, she later became responsible for financial reporting of Multi Data.
In 2002, she joined Tellumat Manufacturing as a Financial Accountant and with the sale of the business unit to a US based company, Stratex Networks, became responsible for managing the full accounting function for the company’s South Africa operations.
She has a BCom degree in accounting from UCT and Bcompt (Hons) from Unisa.

Mark R Goldschmidt is currently a Partner at Holland & Knight LLP, and a Member of both the Massachusetts Bar Association and The Colorado Bar Association.
He was previously a Principal at Patton Boggs LLP and an Infantry Officer in The United States Army (District of Columbia).
Goldschmidt received a graduate degree from Boston College in 2002.

Luís Goldschmidt currently works as a Press Relations Contact for Caixa Geral de Depósitos SA.

Barry Goldschmidt worked as a Treasurer at Wyndham Hotels & Resorts, Inc. from 2019 to 2023.

Adam Goldschmidt has an undergraduate degree from Baruch College.

Daniel Goldschmidt is currently a Director at Danish Aerospace Medical Co. A, M.
Goldschmidt Holding A, and Imerco Holding A.
He was formerly a Director at Aquaporin A.

Mr. Goldschmidt was the co-founder of Yozma and the core of its management team since inception in January 1993.
Mr. Goldschmidt led many of Yozma's investments in Communications and Internet companies, including E-sim (NASDAQ: ESIM), CommTouch (NASDAQ: CTCH), Telegate (acquired by Terayon Communications, NASDAQ: TERN), HarmonyCom - recently received an investment from Cisco (NASDAQ: CSCO), and Trellis Photonics - recently received investment from Agilent (NYSE:A) and Enron (NYSE: ENE).
Prior to joining Yozma, Goldschmidt gained extensive experience as head of the Royalties Department at the Office of the Chief Scientist.
In this capacity Mr. Goldschmidt evaluated investments in hundreds of high-tech companies primarily in the fields of Communications, Software, and Microelectronics.
Mr.Goldschmidt served on Conduit's BOD and later as Conduit's VP Corp Dev.
He is an active investor and his recent investments include: Javelin Medical, Nova sight, Imvision technologies, Minovia Theraputics, Tingo Medical, Triple jump, Nanorep (Acquired by logmein).
Mr. Goldschmidt holds a BA degree in Economics and an MBA degree from the Hebrew University of Jerusalem.

Sophie Goldschmidt is currently the President & Chief Executive Officer at US Ski & Snowboard Team Foundation.
She is also a Director at Rugby International Marketing LLC, Cain Acquisition Corp., and a Governor at International Tennis Hall of Fame, Inc. Her former positions include Chief Executive Officer at Association of Surfing Professionals International LLC from 2017 to 2020, Non-Executive Director at Youth Sport Trust from 2012 to 2018, Group Managing Director at CSM Sport & Entertainment LLP, Non-Executive Director at PGA European Tour from 2012 to 2018, Vice President-Marketing & Sponsorships at Wta Tour, Inc., and Chief Commercial & Marketing Officer at Rugby Football Union from 2011 to 2016.
She received her undergraduate degree from Baylor University.

Mr. Eli Goldschmidt is Executive VP-Communications & Regulations at Israel Corp.
Ltd.
He received his graduate degree from Tel-Aviv University.

Mikael Goldschmidt is the founder and CEO of M.
Goldschmidt Capital A since 2007.
He is currently the CEO of Kalypso Ejendomme ApS and Chairman of Inspiration A, Slotshotellet ApS, and Kokkedal Slot ApS.
He is also the Chairman of M.
Goldschmidt Ejendomme.
A since 2005 and MGE Bolig Hillerød P since 2007, and MGE Bolig Hillerød Holding A since 2011.
He previously served as Chairman of Imerco A.

James E.
Goldschmidt is currently the President-United States at Sandoz, Inc. and the Chief Business Development Officer at CASI Pharmaceuticals, Inc. Previously, he held positions such as Executive Director-Business Development at Johnson & Johnson, Executive Director-Oncology New Business at Wyeth Pharmaceuticals LLC, Product Director at GSK Plc, and Senior Vice President-Business Development at CASI Pharmaceuticals, Inc. He also served as the Vice President-Business & Commercial Development at TetraLogic Pharmaceuticals Corp., Vice President-Business Development at ImmuneXcite, Inc., and Chief Operating Officer at Macrophage Therapeutics, Inc. Dr. Goldschmidt obtained a graduate degree from Drexel University, an undergraduate degree from Villanova University, and a doctorate degree from Temple University School of Medicine.

Martin Goldschmidt is the founder of Cooking Vinyl Ltd.
and Cooking Vinyl Ventures Prodigy Ltd.
which were founded in 1986.
He held the title of Chairman at Cooking Vinyl Ltd.
and President & Managing Director at Cooking Vinyl Ventures Prodigy Ltd.
from 2010 to 2013.
Currently, he holds the position of Director at Cooking Vinyl Holdings Ltd.
and Advisor at Edition Capital Ltd.
Mr. Goldschmidt was also a Director at Essential Music & Marketing Ltd.

Lawrence E.
Goldschmidt is currently the Deputy Chairman at The Jewish Guild for the Blind.

Ms. Paula Goldschmidt is Vice President-Business Development at Liola Technologies Ltd.
Ms. Goldschmidt was previously employed as a Director-Technology & Business Development by Intel Corp.
She received her undergraduate degree from The Hebrew University of Jerusalem and a graduate degree from The Hebrew University of Jerusalem.

Andrew Goldschmidt worked as the Chief Customer Officer at Kenexa Corp.

Nils Goldschmidt currently works at Hamburgisches WeltWirtschaftsInstitut gemeinnützige GmbH, as Research Fellow.

Eliot Goldschmidt worked as a Director at Meridian Capital Group LLC from 2018 to 2021.

Oren Goldschmidt is currently a Managing Director at Pivotus, Inc. He was previously a Managing Director at Umpqua Holdings Corp.
where he worked for Pivotus Ventures Inc.

Peter Goldschmidt currently works as a Director at Eurofins CDMO Alphora, Inc.

Jan Goldschmidt has a current job as a Member-Supervisory Board at Öffentliche Lebensversicherung Braunschweig.

Andreas Goldschmidt currently works at Klinikum Darmstadt GmbH, as Member-Supervisory Board.

Sandra Goldschmidt has a current job as a Member-Supervisory Board at Hamburger Sparkasse AG.

Nathan Goldschmidt is a Member of The Institute of Chartered Accountants in Australia, and a former Chief Financial Officer at Ingenia Communities Group.
He completed his undergraduate degree at The University of New South Wales.

David J.
Goldschmidt is currently a Partner at Skadden, Arps, Slate, Meagher & Flom LLP since 2011.
He is also a Member of the New York State Bar Association.
Mr. Goldschmidt completed his undergraduate degree at New York University in 1984 and his graduate degree at New York University School of Law in 1987.

Roy Goldschmidt is the founder of Astralink Ltd.
He held the title of Chief Marketing Officer at the company, but is no longer active in that role.

Howard Goldschmidt currently works at American Committee for Shaare Zedek Hospital in Jerusalem, as President & Director.

Lutz Goldschmidt currently works at Licht und Kraft GmbH und Co. KG, as Managing Director.